Digital Healthcare
Lucira Health | December 27, 2021
Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced a new agreement with Switch Health Solutions Inc. ("Switch Health") to increase Canadians' access to at-home molecular COVID-19 tests as Omicron cases surge. Lucira will provide more than 2 million at-home COVID-19 test kits in 2022 as part of the deal.
"As Omicron cases surge around the world, the need for better testing solutions has never been more apparent. Only Lucira's tests provide a PCR-quality test result in 30 minutes, wherever you are, from a simple, single-use kit. Making these tests more available is critical to help slow the spread of COVID-19."
Erik Engelson, President and Chief Executive Officer of Lucira
Switch Health is a Canadian healthcare company dedicated to providing better decentralized patient care. Switch Health has quickly become a leader in COVID-19 testing on-site at its Switch Health Clinics and at-home through its remote telehealth service and in-person visits.
"Switch Health's ability to be a Canadian health care leader in decentralized diagnostics is in large part due to the innovative technologies we make available to everyday Canadians," added Marc Thomson, Chief Operating Officer at Switch Health. "Lucira has been an instrumental partner in helping Switch Health achieve that in the COVID-19 era. Together, we are removing barriers to get Canadians safely back to work and reunited with their loved ones."
Last month, Lucira announced confirmation that its COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' can detect 100% of Omicron variant genome sequences analyzed, including the "stealth variant." Lucira assays target viral sequence regions unaffected by the spike protein mutations found in Omicron, Delta, and other variants of concern, allowing it to maintain its accuracy in the face of an evolving virus.
Lucira has received Interim Order authorization from Health Canada to sell and distribute its COVID-19 test kits for at-home self-testing in Canada.
LUCIRA™ CHECK IT Test Kit
The Lucira™ Check-It (OTC) and All-in-One (Rx) test kits are Nucleic-Acid Amplification Tests (referred to as NAAT). The tests fit in the palm of your hand, extract genetic material from the virus and amplify it, similar to PCR lab tests, to detect the presence of virus earlier and more accurately than antigen tests. The test uses an approach called reverse transcriptase loop-mediated isothermal amplification (RT-LAMP). It was designed and tested extensively for individuals to use independently and does not require a physician's prescription or supervised assistance. There is no additional equipment to purchase, such as a reader or instrument.
Each Lucira test kit contains everything needed to run one COVID-19 test. Users get the test device, two AA batteries, sample vial, swab and simple instructions. The batteries are inserted into the device and the sample vial is placed in the test unit. The user then opens the test swab packet and rotates the swab five times in each nostril. The swab is then stirred in the sample vial, which is then gently pressed into the test unit to start the test. The "ready" light will blink until a "positive" or "negative" green light is illuminated within 30 minutes. In the US, Lucira also offers a free LUCI Pass™ digital verified test result back to a user's phone. LUCI Pass is accessed via text and does not require downloading an app. There is also an opt-in for public health reporting for users who wish to transmit their results to the relevant public health authorities.
In clinical trials, 100% of users successfully performed the test at home in about two minutes using Lucira's easy-to-use 'swab, stir and detect' Check-It test kit.
In a Community Trial setting, Lucira™ Check-It results were compared with the Hologic Panther Fusion, considered a high-sensitivity molecular test due to its low Limit of Detection ("LOD"). Lucira's accuracy was 98%, correctly detecting 385 out of 394 positive and negative samples in comparison to the Hologic Panther Fusion, excluding ten samples with very low levels of virus (those with very high PCR cycle thresholds of 37.5 or greater) that possibly no longer represented active infection. Comparative positive results agreed 97% of the time among this sample, and negative results agreed 98% of the time.
About Lucira Health
Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time. The Lucira™ Check-It COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.
Read More
Health Technology
CloudMD Software & Services | November 30, 2021
The need to support Canadians and their mental health has never been greater. To help more people access care, Sun Life is expanding its partnership with CloudMD, the creators of Mental Health Coach. Following a successful seven-month pilot program, Sun Life will begin rolling out Mental Health Coach as part of its Group Benefits offering.
Despite many Canadians experiencing mental health issues, a Sun Life study found over half are not seeking medical care. Cost, access, and feelings of embarrassment are the top barriers to blame. Sun Life and CloudMD are bridging the gap with Mental Health Coach. The service uses data analytics to identify Clients who are at risk of developing a mental health issue. It then proactively reaches out to guide Clients to the right resources and support.
“As the largest provider of group benefits in Canada, we know that tackling the mental health crisis requires dedication and a customized approach. Each person experiences mental health in their own way – no two journeys are the same,” said Dave Jones, President, Sun Life Health. “We’re committed to providing Canadians with innovative and personalized mental health tools to help them wherever they are in their journey. Mental Health Coach is one way we’re helping our Clients live a healthier life.”
A personalized and preventative approach to mental health
A Mental Health Coach team member meets virtually or by phone with the plan member. They walk the plan member through a mental health assessment and create a personalized plan based on the benefits available to them. The Mental Health Coach service monitors the plan members’ progress and provides regular check-ins. They offer feedback and encouragement and can re-assess the plan member at any point in their journey.
During the pilot, Sun Life worked closely with CloudMD to test and refine the Mental Health Coach service. Findings from the Mental Health Coach pilot include:
89% of those experiencing depression and 91% of those experiencing anxiety noticed ‘major improvements’.
73% said they have a better understanding of their benefits.
82% said they would recommend the service based on their own experience.
46% increase in plan members utilizing their mental health benefits for the first time.
“We know that prevention is key when it comes to managing disability claims and connecting plan members with the care they need. The Mental Health Coach provides convenient and effective access to treatment. It can help with many mental health issues before they become severe, which can often lead to people going on disability.”
Karen Adams, President, CloudMD
Select Sun Life Group Benefits Clients will be able to access the Mental Health Coach service as part of their integrated benefits offering. The service will be rolled out and offered across plans throughout 2022.
About Sun Life
Sun Life is a leading international financial services organization providing insurance, wealth and asset management solutions to individual and corporate Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of September 30, 2021, Sun Life had total assets under management of $1.39 trillion.Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America.
Read More
AI
InnerScope Hearing Technologies, Inc. | November 12, 2021
InnerScope Hearing Technologies Inc.("InnerScope"), the leader in direct-to-consumer (DTC) and over-the-counter (OTC) hearing solutions, announced today its partnership with Atlazo Inc. ("Atlazo") to develop next-generation hearing aids and hearable products, utilizing Atlazo's patented Artificial Intelligence (AI) hardware platform. Hearing products powered by Atlazo's proprietary ultra-low power System-on-Chip (SoC) will offer consumers unprecedented new features, including voice commands, continuous health monitoring, and seamless connectivity with other smart devices.
Mr. Adnan Shennib, Chief Technology Officer of InnerScope, stated: "Consumers will not only benefit from improved hearing in noisy environments but also from natural ways to interact with other wireless devices, including mobile phones, providing an enhanced, more convenient, user experience."
Atlazo's integrated digital hardware platform reduces cost and time-to-market for manufacturers of wearable devices. The SoC platforms include software algorithms designed specifically for wearable healthcare applications. The Atlazo and InnerScope collaboration targeting hearing applications are protected by over 12 issued and pending patents.
"We are pleased to join forces with InnerScope and its iHEAR team to develop new types of smart hearing products, leveraging iHEAR's extensive domain experience in hearing health," stated Karim Arabi, Founder and CEO of Atlazo. "Offering new types of intelligent hearing products with improved performance and affordability will be welcomed by tech-savvy consumers looking for alternatives to conventional hearing aids."
"With the recent FDA OTC regulations being released last month, including a landmark proposal intended to improve access to and reduce the cost of hearing aid technology for millions of Americans, and the anticipation of this OTC Law to be enacted soon, InnerScope is continuing to execute its plan to be the leader in the direct-to-consumer hearing device market. The Atlazo partnership and our iHear research and development team give InnerScope the ability to develop new innovative types of proprietary artificial intelligence-powered hearing products that transcend today's hearing devices so all consumers, whether they have hearing loss or not, can benefit from using them."
Matthew Moore, President and CEO of InnerScope Hearing Technologies
About InnerScope Hearing Technologies, Inc
InnerScope Hearing Technologies Inc. is a leading manufacturer and distributor of FDA-registered hearing aids and Personal Sound Amplifier Products (PSAPs) dedicated to addressing the global demand for affordable hearing solutions. InnerScope's hearing products and business models breakthrough persistent barriers that prevent access to effective hearing solutions. With the recent Acquisition of iHear Medical Inc., a cloud-based hearing solution provider with access to over 40 patents, and the completion of HearingAssist Acquisition, an established leader in the direct-to-consumer hearing aid market with over 400,000 customers, InnerScope is well-positioned to expand its distribution partnership network and its leadership in the direct-to-consumer hearing solutions market with advanced hearing products offered at a fraction of the cost of conventional hearing aids sold in hearing aid centers.
About Atlazo
Atlazo is the leader in intelligent semiconductor solutions for healthcare and wearable, targeting the rapidly growing hearing and wearable health device markets. Founded in 2016 and headquartered in San Diego, CA, the company is dedicated to addressing the global demand for more reliable health tracking and audio by bringing together cutting-edge innovations in energy-efficient AI and flexible bio-sensing interface in a single System-on-Chip (SoC) solution. Atlzao's innovative SoC products offer manufacturers a platform for rapid development of wearable healthcare products, dramatically reducing costs and time-to-market.
Read More